Juvenescence website screenshot

Juvenescence

Juvenescence Limited is a clinical-stage, AI-enabled drug development company headquartered in Ramsey, Isle of Man, with operations in the United Kingdom, the United States and Abu Dhabi, founded by Jim Mellon, Dr Gregory Bailey and Dr Declan Doogan and led by CEO Dr Richard Marshall CBE. It develops medicines that target core mechanisms of aging in order to prevent rather than only treat age-related disease, working across small molecules, biologics and cell therapies. Its lead programme is the PAI-1 inhibitor MDI-2517, which completed a Phase 1 trial with a Phase 2 proof-of-concept study planned in metabolic and fibrotic disease, alongside a CD38 inhibitor programme run with the Buck Institute for Research on Aging. The company closed a $76m first tranche of Series B-1 financing led by Abu Dhabi's M42 in 2025 and acquired the AI drug-discovery company Ro5 Inc. in June 2025, bringing in the HydraScreen structure-based screening and ADMET modelling stack. Juvenescence has founded or capitalised a portfolio of longevity biotechs including LyGenesis, Napa Therapeutics, Souvien Therapeutics, Morphoceuticals, Relation Therapeutics, Chrysea Labs, Selah Therapeutics and BYOMass. Juvenescence runs no developer program and publishes no product API. The machine-readable surfaces it does expose are the anonymously readable WordPress REST content API behind juvlabs.com, a provider-published llms.txt, and the open-source HydraScreen and bio2d research code released under the Ro5-ai GitHub organisation.

Juvenescence publishes 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Longevity, and Drug Discovery.

Juvenescence’s developer surface includes documentation, API reference, engineering blog, support, authentication, and 29 more developer resources.

23.5/100 emerging ▼ -6.6 Agent 9/100 agent aware Front door AI 3/6 light saas Full breakdown ↓
scored 2026-10-04 · rubric v0.23.0
AccessOpen
1 API
CompanyBiotechnologyPharmaceuticalsLongevityDrug DiscoveryLife SciencesClinical TrialsArtificial IntelligenceAgingcontent-api

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-10-04 · rubric v0.23.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/juvenescence: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

APIs 1

Individual APIs this provider publishes, each with its own machine-readable definition.

Juvenescence Website (WordPress REST)

The public WordPress REST API (wp-json) of the Juvenescence website at juvlabs.com: the route index of the site's content management system, catalogued as one site surface rathe...

Pricing Plans 1

Published pricing tiers and plan structures.

Rate Limits 1

Documented rate limits and quota policies.

Juvenescence Rate Limits

0 limits

RATE LIMITS

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Juvenescence Authentication

0 schemes

SECURITY

Juvenescence Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Documentation 2

Reference material describing how the API behaves

Agent Surfaces 2

MCP servers, agent skills, and machine-readable catalogs

Design & Contract 5

Pagination, idempotency, versioning, errors, and events

Build 3

SDKs, sample code, and the tooling you integrate with

Access & Security 2

Authentication, authorization, and security posture

Operate 4

Status, limits, changes, and where to get help

Commercial 3

Pricing, plans, and the legal terms of use

Company 5

The organization behind the API

Other 8

Properties that don't map to a standard resource type

Scroll for all 8

Source (apis.yml)

apis.yml Raw ↑
aid: juvenescence
name: Juvenescence
description: Juvenescence Limited is a clinical-stage, AI-enabled drug development company headquartered in Ramsey, Isle of
  Man, with operations in the United Kingdom, the United States and Abu Dhabi, founded by Jim Mellon, Dr Gregory Bailey and
  Dr Declan Doogan and led by CEO Dr Richard Marshall CBE. It develops medicines that target core mechanisms of aging in order
  to prevent rather than only treat age-related disease, working across small molecules, biologics and cell therapies. Its
  lead programme is the PAI-1 inhibitor MDI-2517, which completed a Phase 1 trial with a Phase 2 proof-of-concept study planned
  in metabolic and fibrotic disease, alongside a CD38 inhibitor programme run with the Buck Institute for Research on Aging.
  The company closed a $76m first tranche of Series B-1 financing led by Abu Dhabi's M42 in 2025 and acquired the AI drug-discovery
  company Ro5 Inc. in June 2025, bringing in the HydraScreen structure-based screening and ADMET modelling stack. Juvenescence
  has founded or capitalised a portfolio of longevity biotechs including LyGenesis, Napa Therapeutics, Souvien Therapeutics,
  Morphoceuticals, Relation Therapeutics, Chrysea Labs, Selah Therapeutics and BYOMass. Juvenescence runs no developer program
  and publishes no product API. The machine-readable surfaces it does expose are the anonymously readable WordPress REST content
  API behind juvlabs.com, a provider-published llms.txt, and the open-source HydraScreen and bio2d research code released
  under the Ro5-ai GitHub organisation.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: true
  label: Hosted service · you call their endpoint
  confidence: high
  source:
  - openapi
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: open
  trial: false
  try_now: false
  public: true
  label: Open access
  confidence: medium
  source:
  - authentication
  - rate-limits
  - security
  generated: '2026-09-02'
  method: derived
image: https://juvlabs.com/wp-content/uploads/2024/07/juvenescence-logo-green.png
url: https://raw.githubusercontent.com/api-evangelist/juvenescence/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.23'
created: '2026-08-23'
modified: '2026-08-23'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Longevity
- Drug Discovery
- Life Sciences
- Clinical Trials
- Artificial Intelligence
- Aging
- content-api
tags_raw:
- Company
- biotechnology
- pharmaceuticals
- longevity
- drug-discovery
- life-sciences
- clinical-trials
- artificial-intelligence
- aging
- content-api
apis:
- aid: juvenescence:juvlabs-com-website-wordpress-rest
  name: Juvenescence Website (WordPress REST)
  description: 'The public WordPress REST API (wp-json) of the Juvenescence website at juvlabs.com: the route index of the
    site''s content management system, catalogued as one site surface rather than as separate APIs.'
  baseURL: https://juvlabs.com/wp-json
  tags:
  - WordPress
  x-surface: platform-generated
  properties:
  - type: Documentation
    url: https://juvlabs.com/wp-json
  x-platform: wordpress
  x-platform-surface: rest
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://juvlabs.com/
- type: Documentation
  url: https://developer.wordpress.org/rest-api/
- type: APIReference
  url: https://juvlabs.com/wp-json/wp/v2
- type: Blog
  url: https://juvlabs.com/news/
- type: BlogRSS
  url: https://juvlabs.com/sitemap.rss
- type: PressReleases
  url: https://juvlabs.com/news/category/press-releases/
- type: Publications
  url: https://juvlabs.com/news/category/publications/
- type: Science
  url: https://juvlabs.com/science/
- type: Pipeline
  url: https://juvlabs.com/our-pipeline/
- type: Management
  url: https://juvlabs.com/our-team/
- type: About
  url: https://juvlabs.com/our-approach/
- type: Contact
  url: https://juvlabs.com/contact-us/
- type: Support
  url: https://juvlabs.com/contact-us/
- type: TermsOfService
  url: https://juvlabs.com/terms-of-service/
- type: PrivacyPolicy
  url: https://juvlabs.com/privacy-notice/
- type: CookiePolicy
  url: https://juvlabs.com/cookie-notice/
- type: RefundPolicy
  url: https://juvlabs.com/refund-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/juvenescence1
- type: GitHubOrganization
  url: https://github.com/Ro5-ai
- type: SecondaryMarket
  url: https://forgeglobal.com/juvenescence_stock/
- type: Overlay
  url: overlays/juvenescence-content-overlay.yaml
- type: Authentication
  url: authentication/juvenescence-authentication.yml
- type: Conventions
  url: conventions/juvenescence-conventions.yml
- type: Conformance
  url: conformance/juvenescence-conformance.yml
- type: ErrorCatalog
  url: errors/juvenescence-problem-types.yml
- type: Lifecycle
  url: lifecycle/juvenescence-lifecycle.yml
- type: DataModel
  url: data-model/juvenescence-data-model.yml
- type: DomainSecurity
  url: security/juvenescence-domain-security.yml
- type: Packages
  url: packages/juvenescence-packages.yml
- type: SDKs
  url: packages/juvenescence-packages.yml
- type: Plans
  url: plans/juvenescence-plans-pricing.yml
- type: RateLimits
  url: rate-limits/juvenescence-rate-limits.yml
- type: LLMsTxt
  url: llms/juvenescence-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-23'
  status: enriched
  artifacts_added: 28
  pass: local-v1

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/juvenescence"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/juvenescence/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/juvenescence/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.